Inventor · disambiguated record
Haiqing Hua
Also filed as: HUA HAIQING
7 granted patents·13 pending applications·12 citations·filing 2014–2025
80Inventor score
Files withDUALITY BIOLOGICS SUZHOU CO LTD12JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD2SHANGHAI HANSOH BIOMEDICAL CO LTD2UNIV COLUMBIA2BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
20 records- 0194US11685742B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Jun 27, 2023·5 cites·8 claims
- 0294US11607459B1Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Mar 21, 2023·5 cites·16 claims
- 0393US12091418B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Sep 17, 2024·1 cites·10 claims
- 0493US11952384B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Apr 9, 2024·1 cites·20 claims
- 0589US2025367316A1Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 0687US12168667B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Dec 17, 2024·0 cites·17 claims
- 0784US12434077B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·16 claims
- 0863US2025345443A1Pharmaceutical compound and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0961US2025346673A1Anti-bdca2 antibody and use thereofDUALITY BIOLOGICS SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1061US2025195681A1Anti-gpc3 antibody drug conjugate and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1160US2025002527A1Steroid compound and conjugate thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1260US2025059141A1Tlr modulator and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1360US2025179114A1Anti-Inflammatory Compound and Use ThereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1456US2024165252A1Antibody-drug conjugate and medical use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 1550US2014242038A1Method for generating beta cellsUNIV COLUMBIA·Filed 2014·Application pending·0 cites
- 1647US2018237751A1Method for generating beta cellsUNIV COLUMBIA·Filed 2017·Application pending·0 cites
- 1747US2023190879A1Dual-agonist compound for both glp-1 and gip receptors and application thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1846US2022168396A1Multi-receptor agonist and medical use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 1943US11472882B2Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Oct 18, 2022·0 cites·21 claims
- 2042US2023072897A1Anti-b7-h4 antibody-drug conjugate and medicinal use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiqing Hua files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →